Ch75 Critical care for aneurysm patients Flashcards

(22 cards)

1
Q

What is the evidence for Nimodipine in SAH?

A

British Aneurysm Trial 1989. Compared placebo with oral nimodipine 60mg 4 hourly and started within 4 days of SAH. Rate of cerebral infarction and mortality fell from 33% with placebo to 22% with nimodipine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are risk factor for rebleeding?

A

Hypertension >175 mmHg systolic Female Large aneurysm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the equation for cerebral O2 delivery (DO2)?

A

DO2 = CBF x arterial blood oxygen content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the equation for arterial blood oxygen content?

A

= Sats x Hb x 1.34

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the equation for cerebral perfusion?

A

CPP = MAP - ICP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the equation for cerebral blood flow?

A

CBF = CPP / CVR (cerebral vascular resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can CBF be optimised following SAH?

A

Due to autoregulation increasing CPP does not improve CBF. Avoid hypotension using NorAd (if low HR) or Phenylephrine (if normal HR). Maintain euvolaemia Maintain normal ICP Sats 100% Hb 8-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What was the NEWTON-2 trial?

A

RCT comparison of sustained-release intrathecal Nimodipine vs oral nimodipine. No difference in outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the SAHaRA trial?

A

Comparison of Hb >8 vs Hb>10 for SAH. Still on-going.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do you manage SAH?

A

Admit to ICU HOB 30 and bed rest Fluids 3L AEDs 7 days if aneurysm unsecured Laxative Analgesia Antiemetics BP control Nimodipine PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the evidence for statins in SAH?

A

STASH trial 2014. No benefit with simvastatin 40 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What increases the risk of DNID?

A

Hyponatraemia by 3x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the cause of low Na in SAH?

A

Cerebral Salt Wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Are seizures a predictor of outcome following SAH?

A

Yes, 65% with seizures compared to 23% without. Treat with AEDs for one week until aneurysm secure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the rebleed rate of an unsecured aneurysm?

A

20% @ 14 days and 50% @ 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the evidence for TXA in SAH?

A

Reduces the rebleed rate prior to definitive treatment from 10% to 2%. Hillman et al JNS 2002. Dose of TXA is 1 gram every 6 hours.

17
Q

What is the action of E-aminocaproic acid?

A

Reduces conversion of plasminogen to plasmin. Reduces the risk of rebleed but increases DNID rate.

18
Q

What is neurogenic stress cardiomyopathy?

A

AKA stunned myocardium due to catecholamine surge resulting in reduced cardiac contractility and output. 10% may progress to MI.

19
Q

What proportion of SAH patients have ECG changes?

A

50% - thought to be due to subendocardial ischaemia or coronary artery spasm from catecholamine surge

20
Q

What is the treatment for neurogenic pulmonary oedema?

A

Ventilation with low PEEP and normalisation of ICP

21
Q

What is the main time of risk for vasospasm?

A

3-17 days (peak incidence 6-8 days)

22
Q

What are the clinical features of vasospasm?

A

Non-localising = headache / reduced conciousness / confusion ACA syndrome = incontinence confusion leg weakness MCA syndrome = hemiparesis aphasia and parietal lobe syndromes